by Clini India | May 27, 2025 | Clinical Trials
FDA’s New Guidelines for Adaptive Trial Designs: What Researchers Need to Know In an era where efficiency and flexibility are increasingly valued in clinical research, adaptive trial designs offer a dynamic alternative to traditional, rigid study models. Recently, the...
by Clini India | May 27, 2025 | Clinical Trials
Decentralized Clinical Trials (DCTs): The Future of Patient-Centric Research In the evolving landscape of clinical research, Decentralized Clinical Trials (DCTs) are reshaping how studies are conducted—bringing research directly to the patient, rather than requiring...
by Clini India | May 22, 2025 | Pharmacogenomics
CRISPR and Genome Editing: Are We Ready for Clinical Application? Over the past decade, CRISPR-Cas9 has transformed from a powerful laboratory tool to a potential clinical game-changer. From correcting genetic mutations to engineering immune cells to fight cancer,...
by Clini India | May 15, 2025 | Clinical Trials
How Patient-Centric Approaches Are Redefining Clinical Trial Success The traditional model of clinical trials has long focused on meeting regulatory endpoints—efficacy, safety, and statistical significance. While these metrics remain crucial, they often fail to...
by Clini India | May 15, 2025 | Clinical Trials
Synthetic Control Arms: Reducing the Need for Placebo Groups in Clinical Trials The traditional model of randomized controlled trials (RCTs), long considered the gold standard in clinical research, faces growing scrutiny—especially from patients with serious or rare...
